Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)
Clinical trial NCT03401320 · COMPLETED
Trial details
- NCT number
- NCT03401320
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2024-05-17
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.